280
On the inscrutable role of Inscuteable: structural basis and functional implications for the competitive binding of NuMA and Inscuteable to LGN.
OPEN BIOL
8
120102
0
MARCU R., RAPINO S., TRINEI M., VALENTI G., MARCACCIO M., PELICCI P. G., PAOLUCCI D., GIORGIO M.
Electrochemical study of hydrogen peroxide formation in isolated mitochondria
BIOELECTROCHEMISTRY
85
21 - 28
3,759
MARTELLA S., LOHSIRIWAT V., MEIRELLES BARBALHO D., DELLA VIGNA P., BOTTIGLIERI L., BRAMBULLO T., GOTTARDI A., RIETJENS M., PETIT J. Y.
Sarcoid-like Reaction in Breast Cancer: A Long-term Follow-up Series of Eight Patients
SURG TODAY
MARTIN PADURA I., GREGATO G., MARIGHETTI P., MANCUSO P., CALLERI A., CORSINI C. A., PRUNERI G., MANZOTTI M., LOHSIRIWAT V., RIETJENS M., PETIT J. Y., BERTOLINI F.
The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression.
CANCER RES
MARTIN PADURA I., MARIGHETTI P., AGLIANO A., COLOMBO F., LARZABAL L., REDRADO M., BLEAU A. M., PRIOR C., BERTOLINI F., CALVO A.
Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts.
LAB INVEST
MARTIN-PADURA I., MARIGHETTI P., GREGATO G., AGLIANO A., MALAZZI O., MANCUSO P., PRUNERI G., VIALE A., BERTOLINI F.
Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential.
NEOPLASIA
14
1057 1066
5,946
MARZI M. J., PUGGIONI E. M., DALL'OLIO V., BUCCI G., BERNARD L., BIANCHI F., CRESCENZI M., DI FIORE P. P., NICASSIO F.
Differentiation-associated microRNAs antagonize the Rb-E2F pathway to restrict proliferation.
J CELL BIOL
199
77 - 95
10,264
MATEI D. V., BRESCIA A., MAZZOLENI F., SPINELLI M., MUSI G., MELEGARI S., GALASSO G., DETTI S., DE COBELLI O.
Robot-assisted simple prostatectomy (RASP): does it make sense?
BJU INT
110
e972 e979
2,844
MATEI D. V., RENNE G., PIMENTEL M., SANDRI M. T., ZORZINO L., BOTTERI E., DE CICCO C., MUSI G., BRESCIA A., MAZZOLENI F., TRINGALI V. M., DETTI S., DE COBELLI O.
Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer: A Systematic Diagnostic Attempt.
CLIN GENITOURIN CANC
10
164 - 173
2,605
MATEOS LINDERMANN M. L., RODRIGUEZ DOMINGUEZ M. J., CHACON DE ANTONIO J., SANDRI M. T., TRICCA A., SIDERI M. G., KHIRI H., RAVET S., BOYLE S., ALDRIC C., HALFON P.
Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.
J MOL DIAGN
14
65 - 70
3,576
MAVADDAT N., BARROWDALE D., et al.
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
CANCER EPIDEM BIOMAR
21
134 - 147
4,123
MERONI S., FUNICELLI L., RAMPINELLI C., GALETTA D., BONELLO L., SPAGGIARI L., BELLOMI M.
Solitary fibrous tumors: unusual aspects of a rare disease
HIPPOKRATIA
16
269 - 274
0,525
MESSINA G., GIACCONE L., FESTUCCIA M., IRRERA G., SCORTECHINI I., SORASIO R., GIGLI F., PASSERA R., CAVATTONI I., FILIPPI A. R., SCHIANCA F. C., PINI M., RISITANO A. M., SELLERI C., LEVIS A., MORDINI N., GALLAMINI A., PASTANO R., CASINI M., AGLIETTA M., MONTANARI M., CONSOLE G., BOCCADORO M., RICARDI U., BRUNO B., GRUPPO ITALIANO TRAPIANTI DI MIDOLLO
Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies.
BIOL BLOOD MARROW TR
18
1600 1607
3,873
METZGER-FILHO O., TUTT A., DE AZAMBUJA E., SAINI K. S., VIALE G., LOI S., BRADBURY I., BLISS J. M., AZIM H. A., ELLIS P., DI LEO A., BASELGA J., SOTIRIOU C., PICCART GEBHART M.
Dissecting the Heterogeneity of TripleNegative Breast Cancer.
MICHIELI M., PECCATORI F. A., LLESHI A., DEL PUP L., VALENTE D., RUPOLO M., TIRELLI U., BERRETTA M.
Antiblastic treatment of haematological malignancies during pregnancy: a crucial decision.
INT J IMMUNOPATH PH
25
21S - 32S
MIGLIORI V., MAPELLI M., GUCCIONE E.
On WD40 proteins: propelling our knowledge of transcriptional control?
EPIGENETICS-US
7
815 - 822
IEO — Scientific Report 2012 — Ongoing Research 2013
J CLIN ONCOL
42
72
92
30
259 - 263
325 - 334
952 - 966
1879 1887
MIGLIORI V., MULLER J., PHALKE S., LOW D., BEZZI M., MOK W. C., SAHU S. K., GUNARATNE J., CAPASSO P., BASSI C., CECATIELLO V., DE MARCO A., BLACKSTOCK W., KUZNETSOV V., AMATI B., MAPELLI M., GUCCIONE E.
Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance.
NAT STRUCT MOL BIOL
19
136 - 144
12,712
MILIONE M., PUSCEDDU S., GASPARINI P., MELOTTI F., MAISONNEUVE P., MAZZAFERRO V., DE BRAUD F. G, PELOSI G.
Succinate Dehydrogenase B Subunit Immunohistochemical Expression Predicts Aggressiveness in Well Differentiated Neuroendocrine Tumors of the Ileum
CANCERS
4
808 - 820
0
MINIG L. A., COLOMBO N.
Early stage epithelial ovarian cancer
Textbook of gynaecological oncology - Editors: Ayhan A., Reed N., Gultekin M., Dursun P.
69
429-431
0
MONFARDINI L., DELLA VIGNA P., BONOMO G., ORSI F., TULLII M., DISALVATORE D., MONFARDINI S.
Interventional oncology in the elderly: Complications and early response in liver and kidney malignancies.
J GERIATR ONCOL
MONFARDINI L., ORSI F., MONFARDINI S.
Interventional oncology for older patients in liver and kidney malignancies
AGING HEALTH
8
287 - 288
0
MONTAGNA E., BAGNARDI V., ROTMENSZ N., VIALE G., RENNE G., CANCELLO G., BALDUZZI A., SCARANO E., VERONESI P., LUINI A., ZURRIDA S., MONTI S., MASTROPASQUA M. G., BOTTIGLIERI L., GOLDHIRSCH A., COLLEONI M. A.
Breast cancer subtypes and outcome after local and regional relapse.
ANN ONCOL
23
324 - 331
6,425
MONTAGNA E., CANCELLO G., BAGNARDI V., PASTRELLO D., DELLAPASQUA S., PERRI G., VIALE G., VERONESI P., LUINI A., INTRA M., CALLERI A., RAMPINELLI C., GOLDHIRSCH A., BERTOLINI F., COLLEONI M. A.
Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity.
CLIN BREAST CANCER
12
207 - 214
2,375
MONTANA R. L, GONZALES I. H, RAMIREZ A. A, GARABOLDI L., CHINOL M.
Yttrium-90 - Current Status, Expected Availability and Applications Of A High Beta Energy Emitter.
CURR RADIO
5
253 - 263
0
MONTEMURRO F., ROSSI V., COSSU ROCCA M., MARTINELLO R., VERRI E., REDANA S., ADAMOLI L., VALABREGA G., SAPINO A., AGLIETTA M., VIALE G., GOLDHIRSCH A., NOLE' F.
Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients.
CANCER-AM CANCER SOC
118
17 - 26
4,771
MORO M., CROSTI M., CREO P., GALLINA P., CURTI S., SUGLIANO E., SCAVELLI R., CATTANEO D., CANIDIO E., MARCONI M., REBULLA P., SARMIENTOS P., VIALE G., PAGANI M., ABRIGNANI S.
Identification of new hematopoietic cell subsets with a polyclonal antibody library specific for neglected proteins.
PLOS ONE
7
e34395 e34395
4,092
MUNZONE E., BOTTERI E., ESPOSITO A., SCIANDIVASCI A. S., FRANCHI D., PRUNERI G., ROTMENSZ N., CURIGLIANO G., ADAMOLI L., BOCCIOLONE L., GOLDHIRSCH A., NOLE' F.
Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/ pelvic metastases
ANN ONCOL
23
2884 2890
6,425
MUNZONE E., BOTTERI E., SANDRI M. T., ESPOSITO A., ADAMOLI L., ZORZINO L., SCIANDIVASCI A., CASSATELLA M. C., ROTMENSZ N., AURILIO G., CURIGLIANO G., GOLDHIRSCH A., NOLE F.
Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.
CLIN BREAST CANCER
12
340 - 346
2,375
MUNZONE E., BOTTERI E., SCIANDIVASCI A. S., CURIGLIANO G., NOLE' F., MASTROPASQUA M. G., ROTMENSZ N., COLLEONI M. A., ESPOSITO A., ADAMOLI L., LUINI A., GOLDHIRSCH A., VIALE G.
Prognostic value of Ki-67 labeling index in patients with node-negative, triplenegative breast cancer.
BREAST CANCER RES TR
134
277 - 282
4,431
MUNZONE E., CURIGLIANO G., BURSTEIN H. J., WINER E. P., GOLDHIRSCH A.
CMF revisited in the 21st century.
ANN ONCOL
23
305 - 311
6,425
MUSA M., CROCE A., ALLEGRINA M., RINAUDO C., BELLUSO E., BELLIS D., TOFFALORIO F., VERONESI G.
The use of Raman spectroscopy to identify inorganic phases in iatrogenic pathological lesions of patients with malignant pleural mesothelioma
VIB SPECTROSC
61
66 - 71
1,65
2,991
4,318
NARDINI C., ANNONI M. A., SCHIAVONE G.
Mechanistic understanding in clinical practice: complementing evidence-based medicine with personalized medicine.
J EVAL CLIN PRACT
18
1000 1005
1,229
1,224
7,856
3,641
18,372
Publications
MAPELLI M., GONZALES C.
1
IEO — Scientific Report 2012 — Ongoing Research 2013
281